Home
AJ Vaccines

AJ Vaccines Market Share Analysis for November 2025

AJ Vaccines is a global pharmaceutical company. We develop and manufacture vaccines against serious infectious diseases as well as diagnostic and therapeutic solutions.

Health > Biotechnology and Pharmaceuticals

Domainajvaccines.com

Year Founded2017

Employees501 - 1000

Annual Revenue$200M - $500M

AJ Vaccines

AJ Vaccines (including company regionals)

ajvaccines.com

See more website traffic and engagement information

AJ Vaccines Revenue up to November 2025 is 200M - 500M

revenue generated by AJ Vaccines top domains

AJ Vaccines top domains revenue over 3 years

Revenue for AJ Vaccines top domains

ajvaccines.com200M - 500M

See more with Sales Intelligence

Total visits to AJ Vaccines's top domains

Understand AJ Vaccines market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ajvaccines.com4.3K

See more with Sales Intelligence

Avg. visit duration in AJ Vaccines's top domains

Analyze AJ Vaccines engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ajvaccines.com00:00:12

See more with Sales Intelligence

Avg. pageviews on AJ Vaccines's top domains

See how AJ Vaccines keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ajvaccines.com1.53

See more with Sales Intelligence

AJ Vaccines top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by AJ Vaccines

These are the website technologies, by industry, used by AJ Vaccines top domains

Widget (5)

Twemoji

Advertising (3)

DoubleClick

Mobile (3)

Meta Viewport

Content Management System (2)

WordPress

More Technologies

7

See all

News & Signals from AJ Vaccines

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAJ Vaccines Group hires Ole Vahlgren as CEO.AJ Vaccines is pleased to welcome Ole Vahlgren as its new CEO.

NewsAJ Vaccines Group launched IPV vaccine in Denmark on Jun 1st '19.For instance, in June 2019, AJ Vaccines introduced adjuvant IPV vaccine in Denmark.

NewsAJ Vaccines Group invests into assets: production facilities.In addition, AJ Vaccines has invested significantly in the strategic expansion of its production facilities and recruitment of new employees to secure AJ Vaccines’ position as a significant player in the vaccine market.